Marcin Mardas1,2, Radosław Mądry2, Marta Stelmach-Mardas3,4. 1. Department of Human Nutrition and Hygiene, Poznan University of Life Science, Poznan, Poland. 2. Department of Oncology, Poznan University of Medical Sciences, Poznan, Poland. 3. Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558, Nuthetal, Germany. stelmach@dife.de. 4. Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland. stelmach@dife.de.
Abstract
PURPOSE: This study was conducted to evaluate the dietary intake at different time points of the chemotherapeutic cycle. METHODS: Fifty-five ovarian cancer patients receiving at least 2 cycles of chemotherapy were deemed eligible for this study, of which 41 participants completed the study. Anthropometrical measurements and Subjective Global Assessment were used to estimate nutritional status. The dietary intake was evaluated by 3-day food records: 3 days prior to, the day of, and the following day after chemotherapy. RESULTS: Mean energy intake was the lowest on the day of chemotherapy and the highest 3 days before treatment (mean difference, 413.8 kcal; p < 0.001). Similarly, some vitamins and macro- and micronutrients (K, Ca, vit D, folate, vit C) failed to reach 50 % of the recommended dietary allowances. When dividing patients into BMI categories, the energy intake per kilogram of body weight, in the normal-weight patients, was statistically higher than that in overweight and obese subjects (23.6 vs. 20.9 vs. 12.3 kcal, respectively; p = 0.0015). Similarly, the statistically significant differences were observed by the intake of fats (0.80 vs. 0.69 vs. 0.39 g, p = 0.0283) and carbohydrates (3.52 vs. 3.05 vs. 1.71 g, p = 0.0004). CONCLUSIONS: Dietary intake varies in the cycle of chemotherapy, with the lowest intake at the day of cytotoxic treatment and the highest before the next chemotherapy. Further studies evaluating dietary intake in patients undergoing chemotherapy should include in the protocol the exact time point of dietary assessment. The intake of energy, fats, and carbohydrates differs significantly across BMI categories.
PURPOSE: This study was conducted to evaluate the dietary intake at different time points of the chemotherapeutic cycle. METHODS: Fifty-five ovarian cancerpatients receiving at least 2 cycles of chemotherapy were deemed eligible for this study, of which 41 participants completed the study. Anthropometrical measurements and Subjective Global Assessment were used to estimate nutritional status. The dietary intake was evaluated by 3-day food records: 3 days prior to, the day of, and the following day after chemotherapy. RESULTS: Mean energy intake was the lowest on the day of chemotherapy and the highest 3 days before treatment (mean difference, 413.8 kcal; p < 0.001). Similarly, some vitamins and macro- and micronutrients (K, Ca, vit D, folate, vit C) failed to reach 50 % of the recommended dietary allowances. When dividing patients into BMI categories, the energy intake per kilogram of body weight, in the normal-weight patients, was statistically higher than that in overweight and obese subjects (23.6 vs. 20.9 vs. 12.3 kcal, respectively; p = 0.0015). Similarly, the statistically significant differences were observed by the intake of fats (0.80 vs. 0.69 vs. 0.39 g, p = 0.0283) and carbohydrates (3.52 vs. 3.05 vs. 1.71 g, p = 0.0004). CONCLUSIONS: Dietary intake varies in the cycle of chemotherapy, with the lowest intake at the day of cytotoxic treatment and the highest before the next chemotherapy. Further studies evaluating dietary intake in patients undergoing chemotherapy should include in the protocol the exact time point of dietary assessment. The intake of energy, fats, and carbohydrates differs significantly across BMI categories.
Authors: Z Malihi; M Kandiah; Y M Chan; M Esfandbod; M Vakili; M Hosseinzadeh; M Zarif Yeganeh Journal: Eur J Cancer Care (Engl) Date: 2014-10-30 Impact factor: 2.520
Authors: Anna Boltong; Sanchia Aranda; Russell Keast; Rochelle Wynne; Prudence A Francis; Jacqueline Chirgwin; Karla Gough Journal: PLoS One Date: 2014-07-31 Impact factor: 3.240
Authors: Érica Line de Oliveira Pedron; Rita de Cássia de Aquino; Claudia Borin da Silva Journal: Support Care Cancer Date: 2019-11-27 Impact factor: 3.603
Authors: Jessica Sillas de Freitas; Érica Line de Oliveira Pedron; Joyce de Lima E Silva Aliprandi; Gilberto Cândido Laurentino; Ana Lucia Gatti; Nora Manoukian Forones; Rita de Cássia de Aquino Journal: Support Care Cancer Date: 2022-01-18 Impact factor: 3.603
Authors: Y C de Vries; M M G A van den Berg; J H M de Vries; S Boesveldt; J Th C M de Kruif; N Buist; A Haringhuizen; M Los; D W Sommeijer; J H N Timmer-Bonte; H W M van Laarhoven; M Visser; E Kampman; R M Winkels Journal: Support Care Cancer Date: 2017-03-16 Impact factor: 3.603